Clinical trial

EXoPERT EMERALD Clinical Study

NCT07186296

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-05-09

PhaseN/A

Study timeline

Study start (actual)2025-05-09Date precision: day

Registry last updated2026-07-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Colon Cancerunresolved

Pancreatic Cancerunresolved

Ovarian Cancerunresolved

Lung Cancerunresolved

Interventions

EXoPredDIAGNOSTIC_TEST

Sponsors & collaborators

EXoPERTlead sponsor

MCRAcollaborator

Mapped research locations

Los AngelesCalifornia, United States1 BaltimoreMaryland, United States1 The BronxNew York, United States1 LouisvilleKentucky, United States1 LexingtonKentucky, United States1 Long BeachCalifornia, United States1 HonoluluHawaii, United States1 AlbanyNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07186296 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.